Cardiac Imaging

Coronary CTA (CCTA)

A Coronary CTA (CCTA) is a non invasive heart-imaging test used to determine whether either fatty deposits or calcium deposits, called atherosclerosis, have built up in the coronary arteries which supply blood to the heart muscle. If left untreated, these areas of build-up, called atherosclrotic plaques, can cause blockages of the coronary arteries.  These blockages restrict the blood flow to the heart muscle and can cause heart muscle disease which can lead to fatigue, shortness of breath, chest pain and/or heart attack.  Plaques can also rupture causing a heart attack or Acute Coronary Syndrome. 

Over the last fifteen years, there has been a paradigm shift in our understanding of atherosclerotic plaque. Atherosclerosis is now understood as a systemic  inflammatory process. Calcium scoring alone will give a rough but incomplete picture of overall plaque burden. Intravascular ultrasound is used to assess these plaques, but the procedure is more invasive than coronary angiography. Coronary CTA is the only non-invasive method for imaging these non-obstructing, but potentially dangerous plaques. 
 
A Coronary CTA  is a special type of X-ray examination which uses a CT scanner to image the heart after iodine-containing contrast dye is injected intravenously (IV) into the arm to highlight the blood vessels. Medications are typically given to help slow and stablize the heart rate which leads to a better imaging results. During the examination, which usually takes about 15 minutes,  the CT scanner passes X-rays through the body that are picked up by special detectors in the scanner. The information collected by the CT scanner is then processed using specialized software into 3D images which are used to identify and evaluate the coronary arteries for the presence and degree of plaque.  Typically, 64 slice CT scanners result in clearer final images.  

   

CCTA has consistently shown the ability to rule out significant narrowing of the major coronary arteries and has the ability to detect “soft" or fatty plaque in the walls of the coronary arteries earlier than a coronary angiogram, non-invasively .  These noncalcified, or "soft plaques"  are considered to be at relatively high risk for rupture which can cause myocardial infarction (heart attack) or sudden death.  When undetected these ealry "soft plaques" may lead to future problems without lifestyle changes or medical treatment.  Unfortunately, for 62% of men and 46% of women who have Coronary atherosclerosis, the first indication of coronary artery disease is a heart attack, often resulting in sudden death.  
 

Who should consider Coronary CTA?

The single most important step for patients trying to determine whether they should consider a Coronary CTA is consultation with their primary physician. This is because some Coronary CTA uses are more appropriate than others, and the scan carries some risk from X-ray exposure and contrast dye exposure.

Coronary CTA can detect asymptomatic lesions years in advance of symptoms. This may be of benefit to patients who have intermediate-to-high risk factors for coronary artery disease. The visualization and localization of plaque may aid in the motivation of asymptomatic patients with risk factors or other concerns for coronary artery disease.

CTA is well suited for the assessment of patients with atypical or chronic chest pain who have a low-to-intermediate risk of coronary artery disease. These patients may not warrant the complication and expense of coronary catheterization, but may benefit from the use of Coronary CTA to assess the coronary arteries non-invasively. Other patients for whom there is a diagnostic dilemma and who may not immediately warrant a conventional catheterization, such as patients with equivocal stress tests, can also benefit from the use of a non-invasive intermediate step such as Coronary CTA. This procedure may also benefit patients that have had a negative coronary angiogram but are considered at risk for the presence of soft plaque.

Patients with known coronary artery disease (CAD) experience a life-time of procedures related to their coronary arteries. The judicious use of Coronary CTA, in conjunction with stress perfusion tests, may help resolve diagnostic dilemmas in these patients when new symptoms develop and repeat catheterization is not desirable or indicated.
 

To date, Coronary CTA has not been proven as effective as the coronary angiogram in detecting disease in the smaller heart arteries that branch off the major coronary arteries. For that reason, Coronary CTA is not an adequate substitute for coronary angiography in patients with strong evidence of narrowing of the coronary arteries. Such patients include those with a history of chest pain during heavy physical activity, a history of positive stress-test results, or a known history of coronary artery disease or heart attack. Coronary CTA also is of limited use in patients with extensive areas of old calcified, or hardened, plaque, which is often the case in older patients. Patients who are extremely overweight or who have abnormal heart rhythms also tend not to be suitable candidates for this test because imaging quality is compromised.

 

Download pamphlet about Coronary CT Angiography Imaging

 

For more information about Coronary CT Angiography Imaging, call (916) 732-7777.

Contact NCVI

RAS Vascular Imaging

3161 L St. (Lower Level)
Sacramento, CA 95816

Phone (916) 453-9999

Fax (916) 456-3590

Map Driving Directions

Our Specialists

Vipin Bansal, M.D.

Interventional Radiologist

Dr. Vipin Bansal, Interventional Radiologist, has been with RAS since 1998. He earned his medical degree from the University of California, Los Angeles (UCLA) School of Medicine. Dr. Bansal, a leader in minimally-invasive, image-guided treatments and procedures, completed his residency in Diagnostic Radiology at UCLA Medical Center immediately followed with a fellowship in Vascular and Interventional Radiology. During his fellowship, Dr. Bansal was trained extensively in Uterine Artery Embolizations (UAE/UFE) and later helped to bring this innovative technology to the Sacramento region. In his spare time, Dr. Bansal enjoys basketball and skiing.